Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tom Domovitz"'
Autor:
Shira Perez, Anat Lavi-Itzkovitz, Moriah Gidoni, Tom Domovitz, Roba Dabour, Ishant Khurana, Ateret Davidovich, Ana Tobar, Alejandro Livoff, Evgeny Solomonov, Yaakov Maman, Assam El-Osta, Yishan Tsai, Ming-Lung Yu, Salomon M. Stemmer, Izhak Haviv, Gur Yaari, Meital Gal-Tanamy
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 16, Iss 1, Pp 63-81 (2023)
Background & Aims: Hepatocellular carcinoma (HCC) is a model of a diverse spectrum of cancers because it is induced by well-known etiologies, mainly hepatitis C virus (HCV) and hepatitis B virus. Here, we aimed to identify HCV-specific mutational sig
Externí odkaz:
https://doaj.org/article/2504d44cdec5437d864285de9108428c
Autor:
Tom Domovitz, Samer Ayoub, Michal Werbner, Joel Alter, Lee Izhaki Tavor, Yfat Yahalom-Ronen, Evgeny Tikhonov, Tomer Meirson, Yaakov Maman, Nir Paran, Tomer Israely, Moshe Dessau, Meital Gal-Tanamy
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT Recent studies suggest the enhancement of liver injury in COVID-19 patients infected with Hepatitis C virus (HCV). Hepatocytes express low levels of angiotensin-converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor, raising the possibili
Externí odkaz:
https://doaj.org/article/7a83e1314cde4b69ba8f3d17ef7f1be6
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Autor:
Shira Perez, Antony Kaspi, Tom Domovitz, Ateret Davidovich, Anat Lavi-Itzkovitz, Tomer Meirson, Jacinta Alison Holmes, Chia-Yen Dai, Chung-Feng Huang, Raymond T Chung, Assy Nimer, Assam El-Osta, Gur Yaari, Salomon M Stemmer, Ming-Lung Yu, Izhak Haviv, Meital Gal-Tanamy
Publikováno v:
PLoS Genetics, Vol 15, Iss 6, p e1008181 (2019)
The increasing worldwide prevalence of Hepatocellular carcinoma (HCC), characterized by resistance to conventional chemotherapy, poor prognosis and eventually mortality, place it as a prime target for new modes of prevention and treatment. Hepatitis
Externí odkaz:
https://doaj.org/article/5d55b573e1f747e1963ba5aa57bd0af9
Autor:
Liat Ninio, Abraham Nissani, Tomer Meirson, Tom Domovitz, Alessandro Genna, Shams Twafra, Kolluru D. Srikanth, Roba Dabour, Erez Avraham, Ateret Davidovich, Hava Gil-Henn, Meital Gal-Tanamy
Publikováno v:
Cells, Vol 8, Iss 11, p 1395 (2019)
Hepatocellular carcinoma (HCC) represents the fifth most common cancer worldwide and the third cause of cancer-related mortality. Hepatitis C virus (HCV) is the leading cause of chronic hepatitis, which often results in liver fibrosis, cirrhosis, and
Externí odkaz:
https://doaj.org/article/2116a9b99f8f4498835802f3524446f8
Autor:
Meital Gal-Tanamy, Tom Domovitz
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 551, p 551 (2021)
Journal of Clinical Medicine, Vol 10, Iss 551, p 551 (2021)
Hepatitis C virus (HCV) is a major cause of death and morbidity globally and is a leading cause of hepatocellular carcinoma (HCC). Incidence of HCV infections, as well as HCV-related liver diseases, are increasing. Although now, with new direct actin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d5f6d267cfaa5e9d3b53f85ad30ffa1
http://europepmc.org/articles/PMC7867330
http://europepmc.org/articles/PMC7867330
Autor:
Alessandro Genna, Liat Ninio, Kolluru D. Srikanth, Meital Gal-Tanamy, Roba Dabour, Tom Domovitz, Abraham Nissani, Shams Twafra, Hava Gil-Henn, Ateret Davidovich, Erez Avraham, Tomer Meirson
Publikováno v:
Cells
Volume 8
Issue 11
Cells, Vol 8, Iss 11, p 1395 (2019)
Volume 8
Issue 11
Cells, Vol 8, Iss 11, p 1395 (2019)
Hepatocellular carcinoma (HCC) represents the fifth most common cancer worldwide and the third cause of cancer-related mortality. Hepatitis C virus (HCV) is the leading cause of chronic hepatitis, which often results in liver fibrosis, cirrhosis, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d18db74f7f238f80fddf39e7cf0e912
Autor:
Izhak Haviv, Anat Lavi-Itzkovitz, Jacinta A. Holmes, Antony Kaspi, Chia-Yen Dai, Shira Perez, Meital Gal-Tanamy, Ming-Lung Yu, Tomer Meirson, Salomon M. Stemmer, Assam El-Osta, Ateret Davidovich, Raymond T. Chung, Chung Feng Huang, Gur Yaari, Assy Nimer, Tom Domovitz
Publikováno v:
PLoS Genetics
PLoS Genetics, Vol 15, Iss 6, p e1008181 (2019)
PLoS Genetics, Vol 15, Iss 6, p e1008181 (2019)
The increasing worldwide prevalence of Hepatocellular carcinoma (HCC), characterized by resistance to conventional chemotherapy, poor prognosis and eventually mortality, place it as a prime target for new modes of prevention and treatment. Hepatitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fdd3101ccde5c012b515ab17b6c09c3
https://pubmed.ncbi.nlm.nih.gov/31216276
https://pubmed.ncbi.nlm.nih.gov/31216276